Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy Subjects

Clinical trial NCT02127034 · COMPLETED

Trial details

NCT number: NCT02127034
Sponsor: Astellas Pharma Europe B.V.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects Pharmacokinetics Drug-Drug Interaction (DDI)

Start date: 2014-03-01
Primary completion: 2014-06-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.